CCM
EOLS icon

Coldstream Capital Management’s Evolus EOLS Stock Holding History

Coldstream Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12
Closed -$144 – 1782
2025
Q1 		$144 Buy
+12
New +$157 ﹤0.01% 3495

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Coldstream Capital Management's EOLS Position: Q2 2025 in Review

Coldstream Capital Management sold out of Evolus (EOLS) in Q2 2025, closing a stake of 12 shares — an estimated $144 sold.

Coldstream Capital Management first reported a position in EOLS in Q1 2025 and held it in 1 quarter. The position peaked at $144 in Q1 2025. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Coldstream Capital Management reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 12 Evolus shares in Q2 2025, an estimated $144.
  • Coldstream Capital Management first reported a position in Evolus in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Evolus position peaked at $144 in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.